Masahiro Kagabu

Has grant

Iwate Medical University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

卵巣がんにおける免疫逃避機構改善を目指した新規ウイルス療法の開発

Open Date: 2016-04-01

Close Date: 2018-03-01

Articles (11)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Tsukasa BABA

Professor, Chair

Iwate Medical University

JAPAN

View details

Yohei Chiba

Iwate Medical University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Masahiro Kagabu

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (11)

Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer

Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor

Clinicopathological features and programmed death-ligand 1 immunohistochemical expression in a multicenter cohort of uterine and ovarian melanomas: a retrospective study in Japan (KCOG-G1701s)

Immunosuppressive tumor microenvironment in uterine serous carcinoma via CCL7 signal with myeloid-derived suppressor cells

Sentinel node navigation surgery in cervical cancer: a systematic review and metaanalysis

Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas

Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas

Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study

Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study

Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer

Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer

Collaborators (2)

Tsukasa BABA

Yohei Chiba

Make your next move.